MANIFESTATION OF MULTIFORM EXUDATIVE ERYTHEMA IN THE HEAD OF THE MOUTH IN A PATIENT INFECTED WITH COVID-19
Keywords:
COVID-19, KSHE erythema multiforme, vesiculobullosis, leukemia, Stevens-Johnson syndrome, maculopapular exanthema, papulo-vesicular rash, Herpes simplex virus (HSV).Abstract
Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the oral mucosa. The full range of oral manifestations of COVID-19 is unknown, and the characteristics of oral manifestations of COVID-19, including loss of taste, oral Clinical changes such as lesions and xerostomia are manifested in the oral cavity. The aim of this study is to report a case of oral erythema multiforme (OCE) presenting as oral, lip and skin leukaemias in a patient with COVID-19.
References
S. D. Chowdhury and A. M. Oommen, “Epidemiology of COVID-19,” Journal of Digestive Endoscopy, vol. 11, no. 1, pp. 3–7, 2020.
A. R. Fehr and S. Perlman, “Coronaviruses: an overview of their replication and pathogenesis,” Methods in Molecular Biology , vol. 1282, pp. 1–23, 2015
Wang D, Xu B, Xu K, et al., “Clinical characteristics of 138 patients hospitalized with novel coronavirus pneumonia in Wuhan, China in 2019,” JAMA, vol. 323, no. 11, pp. 1061–1069, 2020 .
Hui D.S., Azhar E.I., Madani T.A. et al., "2019-CoV novel coronaviruses are an ongoing epidemic threat to global health with the latest outbreak of a novel coronavirus in Wuhan, China in 2019," International Journal of Infectious Diseases. 91, pp. 264–266, 2020
N. Chen, M. Zhou, X. Dong et al., “Epidemiological and clinical characteristics of 99 cases of novel coronavirus pneumonia in Wuhan, China in 2019: a descriptive study,” Lancet. 395, no. 10223, pp. 507–513, 2020 year.
M. D. Rodríguez, A. Jiménez Romera, and M. Villarroel, "Oral Manifestations Associated with COVID-19," Oral Diseases, 2020
R. Ansari, M. Geitani, F. Heidari, and F. Heidari, "Oral lesions as a Manifestation of a New Virus (COVID-19)," Oral Diseases. 27, Supplement 3, pp. 771-772, 2021.
A. G. Shaw-Bodar, S. Deneuve, and A. Desautter, "Oral manifestation of Covid-19 as the first symptom?" Journal of Oral Medicine and Oral Surgery. 26, no. 2, p. 18, 2020. M. Sachdeva, R. Gianotti, M. Shah et al., “Cutaneous manifestations of COVID-19: three case reports and review of the literature,” Journal of Dermatology Sciences , vol. 98, no. 2, pp. 75–81, 2020. A. G. Shaw-Bodar, S. Deneuve, and A. Desautter, "Oral manifestations of Covid-19 as the first symptom?" Journal of Oral Medicine and Oral Surgery, Vol. 26, no. 2, p. 18, 2020.
M. Sachdeva, R. Gianotti, M. Shah et al., “Cutaneous manifestations of COVID-19: three case reports and review of the literature,” Journal of Dermatology Sciences , vol. 98, no. 2, pp. 75–81, 2020.
L. Ayanko, and R. S. Rogers, “Oral manifestations of erythema multiforme,” Dermatology Clinics , vol. 21, no. 1, pp. 195–205, 2003 K. A. Al-Johani, S. Fedele, and S. R. Porter, “Erythema multiforme and related disorders,” Oral Surgery, Oral Medicine, Oral trail pathology and oral radiology, vol. 103, no. 5, pp. 642–654, 2007.
MR Lamoreux, MR Sternbach, and WT Hsu, "Erythema multiforme," American Family Physician, vol. 74, no. 11, pp. 1883–1888, 2006.
Paulino L, Hamblin DJ, Osondu N, Amini R. "Variants of erythema multiforme: case report and literature review", Cureus, vol. 10, no. 10, Article e3459, 2018.
Grosber M, Alexander M, Poszepchinska-Guinier E, Revuz J, Rougeau JK. Recurrent erythema multiforme associated with recurrent Mycoplasma pneumoniae infections, Journal of the American Academy of Dermatology. 56, no. 5, pp. S118–S119, 2007 Samim F., Auluck A., Zed C., and Williams PM, "Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and management," Dental Clinics of North America. 57, no. 4, pp. 583–596, 2013.
S. Groeger and J. Meyle, Oral mucosal epithelial cells, Frontiers in Immunology, vol. 10, p. 208, 2019. H. Kokuba, L. Aurelian, and J. Burnett, "Herpes simplex virus-associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-γ and necrosis factor in HAEM leukemias." expressed in tumors. -a - in drugs. Induced Erythema Multiforme Lesions, Journal of Investigative Dermatology, vol. 113, no. 5, pp. 808–815, 1999. R. B. Odom, W. D. James, and T. G. Berger, "Erythema and urticaria," in Andrews' Skin Diseases: Clinical Dermatology, pp. 146-151, Saunders, Philadelphia, PA, 2000.
Capodiferro S., Limongelli L., Favia G. "Oral and maxillofacial manifestations of systemic diseases: a review", Medicina (Kaunas, Lithuania). 57, no. 3, p. 271, 2021.
I. M. Friedberg, A. Z. Eisen, and C. Wolf, Fitzpatrick Dermatology in General Medicine, McGraw Hill, New York, NY, 2003.
V. Hafsi and T. Badri, "Erythema multiforme. [updated 15 Aug 2020]", in Stat Pearls [Internet], Stat Pearls Publishing, Treasure Island (FL), 2021.
Asif S.M., Shamsudin S.M., Assiri K.I. et al., Drug-induced erythema multiforme of the oral cavity: a case report: Medicine, LWW. Internet, 2021.
Mukherjee S., Babu N.A., Malati L. and Anita N., Drug-induced erythema multiforme - a review, European Journal of Molecular and Clinical Medicine. 7, no. 10, pp. 757–763, 2020.
T. Bapst, F. Romano, M. Müller, and M. Rohr, “Specific dermatologic manifestations of pediatric multisystem inflammatory syndrome associated with COVID-19: erythema multiforme,” BMJ Case Reports , vol. 13, no. 6, article e236986, 2020.
EF Gherlone, E. Polizzi, G. Tete et al., "Frequent and persistent salivary gland ectasia and oral cavity disease after COVID-19", Journal of Dental Research. 100, no. 5, pp. 464–471, 2021.
G. Favia, A. Tempesta, G. Barile, et al., "Symptomatic Covid-19 patients with oral lesions: clinical and histopathological study of 123 cases at the Polyclinic of the University Hospital of Bari for the purpose of a new classification," Clinical medical journal. 10, no. 4, p. 757, 2021.
